OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling cascades in the failing heart and emerging therapeutic strategies
Xin He, Tailai Du, Tianxin Long, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Stem cell-based therapy for human diseases
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 617

Exercise training maintains cardiovascular health: signaling pathways involved and potential therapeutics
Huihua Chen, Chen Chen, Michail Spanos, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84

Mitochondrial Structure and Function in Human Heart Failure
Antentor Hinton, Steven M. Claypool, Kit Neikirk, et al.
Circulation Research (2024) Vol. 135, Iss. 2, pp. 372-396
Open Access | Times Cited: 30

CARDIOVASCULAR DISEASE, SIGNALING, GENE/CELL THERAPY AND ADVANCED NANOBIOMATERIALS
Nevzat Erdil
Advances in Biology & Earth Sciences (2024) Vol. 9, Iss. Special Issue, pp. 58-80
Open Access | Times Cited: 27

DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure
Mingjing Yan, Junpeng Gao, Ming Lan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14

Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy
Jichao Zhou, Cai‐Cai Jin, Xiao-Li Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20

High Mobility Group Box 1 (HMGB1): Molecular Signaling and Potential Therapeutic Strategies
Sayantap Datta, Mohammad Atiqur Rahman, Saisudha Koka, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 1946-1946
Open Access | Times Cited: 6

Impact of Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging—What Do We Know So Far? (A Narrative Review)
Cristina Andreea Adam, Răzvan Anghel, Dragoș Traian Marius Marcu, et al.
Life (2022) Vol. 12, Iss. 6, pp. 803-803
Open Access | Times Cited: 27

Recent Advances in Microbiota-Associated Metabolites in Heart Failure
Sepiso K. Masenga, Joreen P. Povia, Propheria C. Lwiindi, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2313-2313
Open Access | Times Cited: 14

Estrogen downregulates CD73/adenosine axis hyperactivity via adaptive modulation PI3K/Akt signaling to prevent myocarditis and arrhythmias during chronic catecholamines stress
Marie Louise Ndzie Noah, Gabriel Komla Adzika, Richard Mprah, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12

The Proteomic Landscape of the Coronary Accessible Heart Cell Surfaceome
Iasmin Inocencio, Alin Rai, D. Donner, et al.
PROTEOMICS (2025)
Closed Access

Anionic lipids direct efficient microfluidic encapsulation of stable and functionally active proteins in lipid nanoparticles
Suresh Ambati, Yeqi Li, Matthew K. Whittaker, et al.
Communications Materials (2025) Vol. 6, Iss. 1
Open Access

Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery
Ashley Wang, Savannah Bitzas, D. Perez, et al.
Life (2025) Vol. 15, Iss. 3, pp. 427-427
Open Access

Impact of plant-derived antioxidants on heart aging: a mechanistic outlook
Muneer Ahmed Khoso, Heng Liu, Tong Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Dysfunctional cardiomyocyte signalling and heart disease
Zara Ridgway, Xuan Li
Current Opinion in Cell Biology (2025) Vol. 94, pp. 102517-102517
Open Access

Myocardial Revascularization in Patients with Diabetes and Heart Failure—A Narrative Review
Stefan Zivkovic, Aleksandar Mandić, Kosta Krupniković, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3398-3398
Open Access

Assessment of urban rail transit network passenger-centered resilience under hazards: A dynamic resilience assessment framework
Ying Lu, Mingxu Yi, Jianqiang Cui, et al.
Accident Analysis & Prevention (2025) Vol. 217, pp. 108042-108042
Closed Access

The long noncoding RNA CARDINAL attenuates cardiac hypertrophy by modulating protein translation
Xin He, Tiqun Yang, Yao Wei Lu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 3

Are Endomyocardial Ventricular Biopsies Useful for Assessing Myocardial Fibrosis?
I. A. Makarov, Daria Voronkina, А. В. Гурщенков, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3275-3275
Open Access | Times Cited: 3

A critical review on advances and challenges of bioprinted cardiac patches
Xiaoqing Zhang, Guangtao Zhao, Tianyi Ma, et al.
Acta Biomaterialia (2024) Vol. 189, pp. 1-24
Closed Access | Times Cited: 3

Defining cardiac fibrosis complexity and regulation towards therapeutic development
Bethany Claridge, Auriane Drack, Alexander R. Pinto, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top